$SFLM Overview - As At August 23,

New Post Public Reply Private Reply Replies (0) Message Board
AJH92
351
$SFLM Overview - As At August 23, 2023

Changes In This Update

- In "New" SFLMaven Corp [$SFLM] - Effective November 15, 2022 Onwards Section - multiple updates at otcmarkets.com August 23, 2023:

-- New Business Description: Holding company for companies purchased and operated under SFLM.

-- New Product Services Description: Holding company that acquires companies in the public markets.

-- New SIC - Industry Classification: 6794 - Patent owners and lessors.

-- SFLM Maven workspace in FL divested and replaced by: Distributed Work Force.

-- Out of date 2nd entry with old CEO Joseph Ladin removed - new CEO had already been added on June 30.

-- Company Profile upgraded to Verified.

- In Trading Patterns - New Business Model - November 15, 2022 Onwards Section - 2023:

- Details of start of breakout: .0006 > .0008 - 33%

- In Share Structure Section:

-- August 22, 2023 update incorporated - no change - no dilution.

-- Days since no change - no dilution to Unrestricted Outstanding Shares updated - now 295 to August 23, 2023.

Backstory

- From October 2020 to November 2022, SFLMaven Corp - ticker $SFLM [formerly $SKDI to March 2021] - comprised only the wholly owned subsidiary SFLMaven of Florida, LLC - a Top Rated eBay seller of jewelry in business for 19+ years.

- Despite SFLMaven of Florida, LLC increasing gross revenue by 35% in 2021 over 2020 - and being on track for a further 15%>20% increase in 2022, it was still operating at a net loss in 2022 Q3 after taking into account large past adjustments for eBay seller's fees in earlier backdated periods.

"New" SFLMaven Corp [$SFLM] - Effective November 15, 2022 Onwards

On November 15, 2022, it was PR'ed that:

- Chad MacKay had been appointed as Chairman and CEO of SFLMaven Corp [replacing Joe Ladin].

- He will oversee the launch of the Company’s new business plan that focuses on acquisitions or technology licensing opportunities.

- The Company will focus on identifying companies and/or technologies that could be impactful in their respective industries.

- Chad MacKay is the co-founder and managing partner of Loyal Companies, a private equity firm focusing on mergers and acquisitions.

- The Company’s previous Chairman and CEO, Joseph Ladin, resigned as Chairman and CEO as part of these changes.

- SFLMaven Corp decided to divest of its operating subsidiary, SFLMaven of Florida, LLC and this was completed as planned in November 2022.

- The 2022 Annual Report was filed on April 17, 2023 signed by the new CEO.

- The $SFLM record with WYSOS was updated on May 12, 2023 showing:

-- Now Active - Current.

-- Upgraded to in Good Standing for Tax and all other categories.

-- Changed the registered Principal Office address to Salt Lake City, UT after divesting the previous loss-making business in FL.

- The $SFLM record at otcmarkets.com started to get updated on June 30, 2023, as follows:

-- New HQ address in UT: now 12884 S Frontrunner Blvd, Draper, UT 84020.

--- Interior views of the upscale corporate workspace suites in this building here:

https://d3vfz99dlfnk1r.cloudfront.net/uploads...397477.jpg

https://d3vfz99dlfnk1r.cloudfront.net/uploads...65b551.jpg

-- Chad MacKay added as CEO, CFO and Sec.

-- Website for divested subsidiary SFL Maven of FL removed.

- Multiple further updates at otcmarkets.com on August 23, 2023:

-- New Business Description: Holding company for companies purchased and operated under SFLM.

-- New Product Services Description: Holding company that acquires companies in the public markets.

-- New SIC - Industry Classification: 6794 - Patent owners and lessors.

-- SFLM Maven workspace in FL divested and replaced by: Distributed Work Force.

-- Out of date 2nd entry with old CEO Joseph Ladin removed - new CEO had already been added on June 30.

-- Company Profile upgraded to Verified.

$SFLM CEO - Chad MacKay

- Prior to joining Loyal Companies, Chad MacKay was founder and managing partner of Kai Data Companies.

- He has been actively involved as a director with other companies and organizations. Among the boards on which he serves currently and in the past are: Loyal Companies, Revvu, Cumulus, Cumulus Advanced Technologies, Kai Data, Vulcan7, Espresso Agent, Team Leads, Bear River Management Group, Kai Insurance, Synergy Holdings, RAD, Loyal Technologies, Trustee for Chase N' Heaven and Brother's Keeper.

- In the November 15, 2022 PR he stated:

- “I am very excited to become a part of SFLMaven Corp as the Company’s Chairman and CEO."

- "I have been in private equity for the past 15 years and have done a lot of exciting deals."

- "Our team has built an impressive deal flow of prospects that could be acquired or technology that could be licensed by SFLM.”

- “Our goal will be to add acquisitions and/or licensing agreements to technologies that we believe will be accretive to the Company and our Shareholders. For example, we are working with one credible University on some amazing technologies in the lithium mining industry that could be really important to the future of electric batteries."

- "Where it makes sense to focus on specific verticals, we will. If we find Companies that could benefit by being a part of the SFLM family of companies we will evaluate those.

- "We have an aggressive team and look forward providing more detailed updates in the near future.”

$SFLM CEO Linkedin Profile:

https://www.linkedin.com/in/chad-mackay-2b3417156

Loyal Companies website: https://www.loyalcompanies.com/

"New" $SFLM PRs Since November 15, 2022

Ongoing PR campaign with 1 release to date.

News - November 15. SFLMaven Corp. Announces the Appointment of Chad MacKay as Chairman and CEO and Announces New Business Plan.

https://www.otcmarkets.com/stock/SFLM/news/SF...?id=380331

2022 Annual Report

Confirmed that:

- The loss-making subsidiary SFL Maven of Florida LLC had been divested as planned in November 2022.

- The new business direction was still as described in the last PR - technology licensing and / or acquisition with a promising lead being lithium mining for batteries.

Current Tier - OTC Pink Limited

"OTC Markets Group has confirmed that this company has limited disclosure or financial information publicly available, but meets a minimum requirement for public quoting under Rule 15c2-11."

Share Structure - Updated August 22, 2023

Verified Profile - updated at least monthly.

Authorized Shares: 5,000,000,000 [same as in January 2020]

Outstanding Shares: 2,238,709,801 [no change]

Restricted: 219,001,359 [no change]

Unrestricted: 2,019,708,442 [no change]

Note1: It is only the Unrestricted Outstanding Shares count that is relevant to immediate trading. This is relatively low at 2.02B for a stock in the .0008 > .25 price range.

Note 2: There has now been no change to the Unrestricted Outstanding Shares November 2 > August 23 - total 295 days.

Trading Patterns - Previous Business Model - 2021 > November 14, 2022

Note 1: Details of runs in 2019 and 2020 of up to 433% have been deleted - still available to view in the contemporaneous record here.

Note 2: Now that we are expecting runs of 1000% > 2000% in 2023 from current levels, details of 8 x runs less than 84% in 2021 prior to the main move up have been deleted .

2021

Started breakout from .0038 (previous close) > .0050 on January 6, 2021

Ran from .0052 > .0064 on February 9 - 23%

Ran from .0062 > .0080 on February 10 - 29%

Ran from .0073 > .0091 on February 11 - 25%

Ran from .0070 > .0088 on February 18 - 26%

Ran from .0076 > .0091 on March 3 - 20%

Ran from .0086 (previous close) > .0197 (then new 2021 high) on March 24 - 129%

Ran from .0092 (previous close) > .0169 on March 29 on just under 99M traded - 84%

Ran from .0169 (previous close) > .0200 (new 2021 high) on March 30 - 18%

Ran from .0127 (previous close) > .0160 on April 1 on just 28M traded - 26%

Ran from .0098 (previous close ) > .0119 on April 8 - 21%

Ran from .0060 (previous close) > .0117 on July 15 - 95%

Ran from .0018 (days prior) > .0030 by December 14 - 66%

2022

Ran from .0018 > .0024 on February 4 - 33%

Ran from .0008 > .0014 by March 7+8 - 75%

Ran from .0008 (previous close ask) > .0011 on April 22 - 37.5%

Ran from .0009 (previous close ask) > .0012 on April 27 - 33%

Ran from .0007 (available previously) > .0012 on September 7 - 71%

Ran from .0005 (previous close) > .0007 on September 30 - 40%

Trading Patterns - New Business Model - November 15, 2022 Onwards

2022

Ran from .0004 > .0007 on November 15 - 75%

Ran from .0007 > .0010 on November 18 - 43%

2023

Moved up from .0004 > .0005 on February 16 - 25%

Moved up from .0005 > .0006 on March 16 - 20%

Started breakout on July 5, 2023 - undercut ask of 20M at .0005 bought out

Ran from .0005 > .0009 on July 5 - 80%

Ran from .0006 > .0008 on August 23 - 33%

With confirmation of the CEO change, the 2022 Annual Report filed, WY SOS updates of May 12 and now the latest Company Profile updates at otcmarkets.com on August 23, including the SIC change to "patent owners and lessors", we should see significant additional buying in the near future and over the next few weeks/months into 2024.

Ex pect a dramatic move up anytime we get sufficiently large buys set across several successive asks - as happened on November 15 and November 18, 2022.

We should get past any remaining mass 1-tick flippers by .0010 and
get back to a more normal few M per .0001 from .0011 > .0020 then much thinner still after that all the way to the .01>.02+ range IMO based on detailed record keeping over the last few years since $SFLM was last at .02.

As with all my long-term top picks, knowing who got what where - relative to you by process of elimination - is important when deciding the ratio of shares to keep long-term vs locking in partial profits at peaks in the .01 > .02+ range - as is patience - this is a long-term play throughout 2023 and into 2024.

Performance and Outlook

$SFLM will remain a potential top profit pick for me throughout 2023 and into 2024 for self-evident reasons in this Overview.

Performance in each year 2020 > 2022 has shown that it pays to be ready at all times for surges with tradeable lots from multiple price points - not just trying to get the cheapest of the year and stretch them.

Continued large profit trading opportunities are anticipated ahead throughout 2023 and future years for those who maintain a large inventory of shares at a variety of price points. Having plenty of shares - you don't need the cheapest - avoids the need to chase every time it runs.

With some OTC tickers now adding 10 Billion - even 50 Billion - shares per update, $SFLM remains one of the thinnest sub .02 tickers in the OTC with an immediately tradeable Unrestricted Outstanding shares count of only 2.019 Billion unchanged for 295 days as at August 23, 2023.

Cancel any left over ask sell orders at close to get the maximum gap up at each open.

Expect .02+ at some point ahead in 2023 / later years and watch out for the following catalysts:

- Momentum move up ahead of updates through former long-term bidders and new interest taking the small offered asks causing bidders to commit to ask buying while they still can under .0020.

- Updates on the "impressive deal flow of prospects that could be acquired or technology that could be licensed by SFLM” [source: PR November 15, 2022]

- Updates on the lithium mining initiative for batteries.

- Updates on acqui sitions, patents and licensing.

- Possible name change.

- Possible ticker change.

SEC Action Against Actions Of Previous CEO - Matter Now Closed

The SEC had been investigating the old company under the previous CEO for selling unregistered offerings October 10, 2019 up to December 9, 2021. This accounted for why share increases declared monthly at otcmarkets.com during that period appeared to be insignificant compared to the total volume traded in each period. The matter is now closed with $SFLM agreeing to pay a $25K fine in quarterly installments.

SEC notices linked here:

https://www.sec.gov/news/press-release/2023-9...ovdelivery

https://www.sec.gov/files/litigation/admin/2023/33-11188.pdf

Not a financial advisor - just stating what I'm basing my trading decisions on.

I will be holding some $SFLM in my portfolio throughout 2023 and into 2024 for long-term growth, trading some on surges from the bottom up too and reloading on any dips.




SFLMaven, Inc. (SFLM) Stock Research Links

SFLM Board Company Profile Buy Rating Time & Sales News Filings Financials
"Per Ardua Ad Astra" - "Through Adversity To The Stars"

A very apposite motto for those who trade successfully in the OTC market..

All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Boston STEM Expo Sparks Young Minds in Engineering

Updated Category News Views 286

If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 188

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 206

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 21

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 105

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 271

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 98

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 61

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 630

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 337

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading

Top 5 Most Recently Viewed Articles

Insights on 74Software's Voting Rights and Share Capital Details

Updated Category News Views 182

Understanding Voting Rights and Share Capital of 74Software In a recent communication, 74Software shared vital information regarding its voting rights and total share capital. As a company with a rich background in enterprise software, they remain committed to transparency with their shareholders. Highlights of Total Shares As of August 31, 2025, the total number of...

Continue Reading
Tenon Medical Earnings Report: Insights and Predictions Ahead

Updated Category News Views 125

Insights into Tenon Medical's Upcoming Earnings As the market anticipates the upcoming earnings release from Tenon Medical Inc (NASDAQ: TNON), investors are eager to understand what the future holds for the company. While the earnings date is set, the focus is largely on the earnings per share (EPS) forecasted at $-0.47. This brings both concern and hope as stakeholders...

Continue Reading
Cahill's New Counsel James Mandolfo Strengthens Investigations Team

Updated Category News Views 95

Cahill's New Counsel James Mandolfo Strengthens Investigations Team Cahill Gordon & Reindel LLP, a prestigious law firm known for its expertise and long-standing reputation in the legal field, has recently added James Mandolfo to its team. As part of the Congressional Investigations and White Collar Defense & Investigations practices, James brings a wealth of knowledge...

Continue Reading
Capstone Infrastructure Unveils Landmark Wind Projects with Partners

Updated Category News Views 311

Capstone Infrastructure's New Renewable Energy Initiatives Toronto, Ontario — Capstone Infrastructure Corporation (TSX: CSE.PR.A) is excited to share its involvement in three critical wind energy projects in collaboration with Indigenous partners. These projects highlight the Corporation's commitment to sustainable energy solutions and community empowerment....

Continue Reading
Investigation Raises Questions for Encompass Health Investors

Updated Category News Views 211

Investigation into Encompass Health Corporation Pomerantz LLP is currently conducting an investigation on behalf of investors in Encompass Health Corporation (NYSE: EHC). This investigation aims to uncover whether there have been any incidents of securities fraud or other unlawful business practices involving the company and its executives. Allegations of Unlawful...

Continue Reading